Yi-Long Wu
MD
Director, Guangdong Lung Cancer Institute
👥Biography 个人简介
Yi-Long Wu is one of the most influential thoracic oncologists in Asia who has shaped EGFR-targeted therapy through multiple landmark trials including ADAURA and FLAURA. His work on adjuvant and neoadjuvant EGFR TKI therapy has been transformative for the large EGFR-mutant lung cancer population in Asia. He leads the Guangdong Lung Cancer Institute as a global research hub.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Yi-Long Wu 的研究动态
Follow Yi-Long Wu's research updates
留下邮箱，当我们发布与 Yi-Long Wu（Guangdong Provincial People's Hospital）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment